|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
RRC | FINKELSON ALLEN | Director | Apr 30 | Option Exercise | 62.06 | 6,509 | 403,949 | 81,509 | May 04 04:49 PM |
RRC | FINKELSON ALLEN | Director | Apr 30 | Sale | 62.50 | 1,735 | 108,437 | 75,000 | May 04 04:49 PM |
RRC | FINKELSON ALLEN | Director | Jan 02 | Option Exercise | 84.31 | 6,941 | 585,196 | 81,941 | Jan 03 05:09 PM |
RRC | FINKELSON ALLEN | Director | Jan 02 | Sale | 83.21 | 3,516 | 292,580 | 75,000 | Jan 03 05:09 PM |
RRC | FINKELSON ALLEN | Director | Mar 18 | Option Exercise | 82.00 | 4,414 | 361,948 | 79,414 | Mar 19 05:59 PM |
RRC | FINKELSON ALLEN | Director | Mar 18 | Sale | 81.97 | 376 | 30,821 | 75,000 | Mar 19 05:59 PM |
RRC | FINKELSON ALLEN | Director | Mar 18 | Sale | 81.90 | 2,098 | 171,833 | 0 | Mar 19 05:59 PM |
RRC | FINKELSON ALLEN | Director | Apr 27 | Option Exercise | 62.64 | 7,350 | 460,404 | 82,350 | May 01 06:26 PM |
RRC | FINKELSON ALLEN | Director | Apr 27 | Sale | 62.16 | 2,888 | 179,519 | 75,000 | May 01 06:26 PM |
RRC | FINKELSON ALLEN | Director | Jul 27 | Sale | 64.49 | 34,494 | 2,224,411 | 0 | Jul 28 06:39 PM |
RRC | FINKELSON ALLEN | Director | Feb 15 | Option Exercise | 26.59 | 24,000 | 638,040 | 99,000 | Feb 16 06:37 PM |
RRC | FINKELSON ALLEN | Director | Feb 15 | Sale | 48.67 | 18,062 | 879,068 | 75,000 | Feb 16 06:37 PM |
RRC | FINKELSON ALLEN | Director | Nov 09 | Option Exercise | 8.17 | 24,000 | 196,180 | 99,000 | Nov 10 08:29 PM |
RRC | FINKELSON ALLEN | Director | Nov 09 | Sale | 52.01 | 24,000 | 1,248,358 | 75,000 | Nov 10 08:29 PM |
RRC | FINKELSON ALLEN | Director | Nov 14 | Option Exercise | 5.37 | 24,000 | 128,899 | 87,000 | Nov 14 03:40 PM |
RRC | FINKELSON ALLEN | Director | Nov 14 | Sale | 40.06 | 24,000 | 961,454 | 75,000 | Nov 14 03:40 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite